UNICREDIT BANK/CALL/BIOGEN IDEC/220/0.1/15.01.25 Stock

Warrant

DE000HD31TH4

Real-time BOERSE MUENCHEN 07:40:57 2024-07-02 EDT
3.15 EUR +2.61% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/220/0.1/15.01.25
Current month+4.78%
1 month+8.87%
Date Price Change
24-07-02 3.15 +2.61%
24-07-01 3.07 +4.78%
24-06-28 2.93 +0.69%
24-06-27 2.91 +11.49%
24-06-26 2.61 +0.77%

Real-time BOERSE MUENCHEN

Last update July 02, 2024 at 07:40 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD31TH
ISINDE000HD31TH4
Date issued 2024-02-26
Strike 220 $
Maturity 2025-01-15 (198 Days)
Parity 10 : 1
Emission price 3.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.52
Lowest since issue 1.47
Delta0.68x
Omega 4.852
Premium8.84x
Gearing7.19x
Moneyness 1.054
Difference Strike -11.77 $
Difference Strike %-5.35%
Spread 0.06
Spread %1.97%
Theoretical value 3.135
Implied Volatility 35.93 %
Total Loss Probability 42.92 %
Intrinsic value 1.098
Present value 2.037
Break even 253.61 €
Theta-0.05x
Vega0.06x
Rho0.06x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8 USD
Average target price
283.2 USD
Spread / Average Target
+22.17%
Consensus